Adicet Bio, Inc.
ACETNasdaqCIK 1720580HealthcareFiscal year ends Dec 26
Reports and events: 223 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-08-1307:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095745 |
| 2024-08-1307:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095744 |
| 2024-07-0807:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-081943 |
| 2024-06-2407:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-076460 |
| 2024-06-0716:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-070568 |
| 2024-06-0507:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-069067 |
| 2024-05-1416:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-059507 |
| 2024-05-1416:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-059496 |
| 2024-05-1006:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-057429 |
| 2024-04-2317:03 ET | DEF 14A | Proxy statementPeriod 2024-04-23 | 0000950170-24-047034 |
| 2024-04-2216:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-046459 |
| 2024-03-2216:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-035366 |
| 2024-03-2116:31 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-24-000300 |
| 2024-03-1916:15 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-033482 |
| 2024-03-1916:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-033476 |
| 2024-02-0716:31 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-026734 |
| 2024-01-2916:55 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-24-000074 |
| 2024-01-2416:34 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-007011 |
| 2024-01-1607:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-004403 |
| 2024-01-0407:17 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-001490 |
| 2023-11-1316:42 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-063062 |
| 2023-11-0816:14 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061128 |
| 2023-11-0816:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-061121 |
| 2023-08-0916:20 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040631 |
| 2023-08-0916:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-040617 |
| 2023-07-1108:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-032449 |
| 2023-06-2916:30 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-23-000710 |
| 2023-06-2616:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-029851 |
| 2023-06-0516:52 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-23-026406 |
| 2023-06-0517:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-23-026198 |
| 2023-05-1806:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-022865 |
| 2023-05-0916:17 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-019700 |
| 2023-05-0916:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-019685 |
| 2023-04-1816:30 ET | DEF 14A | Proxy statementPeriod 2022-12-31 | 0000950170-23-013294 |
| 2023-03-1516:07 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-008130 |
| 2023-03-1516:04 ET | 8-K | 2.02 Results of operations | 0000950170-23-008122 |
| 2023-03-1015:46 ET | 8-K | 7.01 Regulation FD disclosure | 0000950170-23-007252 |
| 2022-12-1206:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-026329 |
| 2022-12-0816:09 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-22-026232 |
| 2022-11-1017:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-024573 |
| 2022-11-0816:16 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-023230 |
| 2022-11-0816:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-023224 |
| 2022-11-0309:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-021598 |
| 2022-10-0508:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-019282 |
| 2022-08-1117:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-22-218665 |
| 2022-08-1007:09 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016254 |
| 2022-08-1007:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-016250 |
| 2022-06-2117:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-22-011916 |
| 2022-06-0616:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-011219 |
| 2022-06-0316:32 ET | 8-K | 5.07 Shareholder vote results | 0000950170-22-011172 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:00 ET. Listed shows no prices and gives no investment advice.